Evidence map›Paper›PMID 32419059›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2020

Measuring intangible cost-of-morbidity due to substance dependence: implications of using alternative preference-based instruments.

Bruno Casal, Eva Rodríguez-Míguez, Berta Rivera

Abstract read
PubMed Publisher
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bruno CasalDepartment of Economics, University of A Coruña, Campus de Elviña, 15071, A Coruña, Spain.
Eva Rodríguez-MíguezDepartment of Applied Economics, University of Vigo, Campus As Lagoas-Marcosende, 36310, Vigo, Spain.
Berta RiveraDepartment of Economics, University of A Coruña, Campus de Elviña, 15071, A Coruña, Spain. berta.rivera@udc.es.ORCID http://orcid.org/0000-0002-0687-9883

Funding

Ministerio de Ciencia, Innovación y Universidades RTI2018-099403-B-I00Ministerio de Sanidad, Servicios Sociales e Igualdad 2013I027
6 · The paper itself

Abstract

objectiveDrug and/or alcohol dependence (DAD) generates substantial costs to society. One of the main consequences of DAD is its negative impact on health-related quality of life (HRQoL). The main objective of this study is to analyse the impact of using EQ-5D-5L, SF-6D

methodsA convenience sample of 109 patients with a diagnosis of substance use disorder was recruited. SF-6D and EQ-5D-5L were administered and then the utility scores were computed. The impact of employing different instruments to estimate the HRQoL burden was assessed by comparing the utility scores of patients and general population after controlling for sex and age through regression analysis. The analysis was reproduced for two subgroups of severity.

resultsAll instruments detect that DAD significantly affects the HRQoL. However, the estimated impact changes, according to the instrument used, whose pattern varies by severity group. Nonetheless, regardless of severity, SF-6D

conclusionsThe SF-6D

Indexed as

Cost of IllnessQuality of LifeAdolescentAdultAgedAlcoholismCost-Benefit AnalysisFemaleHealth Status IndicatorsHumansMaleMiddle AgedMorbidityPsychometricsSubstance-Related DisordersYoung AdultEQ-5D-5LIntangible costPaired-gambleSF-6DSubstance dependence

Identifiers

PMID32419059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.